All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles - the global online resource for all aspects of gastroenterology, hepatology and endoscopy - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder


Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links

Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS


Latest impact factors for gastroenterology and hepatology journals

Interesting changes have been revealed from the latest gastroenterology and hepatology journal impact factors, for the year 2000.

News image

Gastroenterology is still the journal with the greatest impact factor, followed by Hepatology.

However, now in third place is Seminars in Liver Disease. This journal was 7th in 1999. Gut has therefore been displaced into 4th place.

Alimentary Pharmacology & Therapeutics is another improver - it has moved up to 6th place, from last year's position of 8th.

The impact factors are published by ISI. Their definition of an impact factor is "a measure of the frequency with which the 'average article' in a journal has been cited in a particular year or period."

The annual journal citation report impact factor is a ratio between citations and recent citable items published. Thus, the impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.

Journals with greatest impact:
1 Gastroenterology
2 Hepatology
3 Semin Liver Dis
4 Gut
5 J Hepatol
6 Aliment Pharmacol Ther

ISI explain that, "The impact factor is useful in clarifying the significance of absolute (or total) citation frequencies. It eliminates some of the bias of such counts, which favor large journals over small ones, or frequently issued journals over less frequently issued ones, and of older journals over newer ones. Particularly in the latter case such journals have a larger citable body of literature than smaller or younger journals.

"All things being equal, the larger the number of previously published articles, the more often a journal will be cited."

Here is the "Top Forty Four" of the impact factors for 2000:

Journal    Impact factor
Gastroenterology    12.246
Hepatology    7.304
Semin Liver Dis    6.012
Gut    5.386
J Hepatol    3.761
Aliment Pharmacol Ther    3.489
Am J Physiol-Gastr L    3.115
Am J Gastroenterol    2.834
Gastrointest Endosc    2.820
Helicobacter    2.639
J Viral Hepat    2.157
Liver Transplant    2.130
Neurogastroenterol Motil    2.081
Scand J Gastroenterol    1.842
Endoscopy    1.817
Hepatol Res    1.808
Inflamm Bowel Dis    1.791
Digestion    1.780
Gastroenterol Clin North Am    1.774
Liver    1.739
Bailliere Clin Gastr    1.733
Int J Colorectal Dis    1.707
Dis Colon Rectum    1.690
Can J Gastroenterol    1.645
J Pediatr Gastroenterol Nutr    1.580
Dig Dis Sci    1.498
Ital J Gastroenterol    1.289
Eur J Gastroenterol Hepatol    1.142
J Clin Gastroenterol    1.127
J Gastroenterol Hepatol    1.116
World J Gastroenterol    0.993
J Gastroenterol    0.990
Gastroen Clin Biol    0.927
Hepato-Gastroenterol    0.905
Z Gatsroenterol    0.887
Abdom Imaging    0.886
Dig Surg    0.810
Dig Dis    0.744
Acta Gastro-Ent Belg    0.605
Curr Opin Gastroen    0.577
Rev Esp Enferm Dig    0.384
J Diarrhoel Dis Res    0.379
Chir Gastroenterol    0.078
Best Pract Res Cl Ga    0.067

03 September 2001

Go to top of page Email this page Email this page to a colleague

 22 October 2014

Advanced search
 22 October 2014 
Liver fibrosis prognostic biomarkers in type-2 diabetes
 22 October 2014 
H pylori eradication with multiple drug resistance
 22 October 2014 
Early-TIPSS placement prevents rebleeding
 21 October 2014 
Scoring systems for critically ill cirrhotic patients
 21 October 2014 
Aspirin and NAFLD
 21 October 2014 
Alcohol and Barrett's
 20 October 2014 
Drug resistant H pylori eradication
 20 October 2014 
Adalimumab in secondary loss of response in Crohn's
 20 October 2014 
Omega-3 and colorectal cancer
 17 October 2014 
Colorectal testing utilization
 17 October 2014 
Fecal microbiota composition in postinfectious IBS
 17 October 2014 
Tumor necrosis factor-alpha inhibitors and pregnancy in IBD
 16 October 2014 
Risk of Barrett's esophagus
 16 October 2014 
Aspirin tablets and colorectal tumours
 16 October 2014 
Economic impact of IBS
 15 October 2014 
Achieving competency at colonoscopy
 15 October 2014 
Preparation for surgery in Crohn's
 15 October 2014 
Bowel preparations
 14 October 2014 
Colorectal testing utilization in commercially insured US adults
 14 October 2014 
Sustained response to infliximab
 14 October 2014 
IBD management during pregnancy
 13 October 2014 
Predicting PPI response in GERD-related cough
 13 October 2014 
Probiotics in IBS
 13 October 2014 
Use of azathioprine in IBD
 10 October 2014 
NAFLD in the Veterans Administration population
 10 October 2014 
Liver injury from herbals and dietary supplements
 10 October 2014 
Predictors for cecal insertion time
 09 October 2014 
Methotrexate-related liver disease and metabolic syndrome
 09 October 2014 
Biomarkers of acetaminophen overdose patients
 09 October 2014 
Postoperative adhesions in digestive surgery
 08 October 2014 
Feeding intervention in celiac disease infants
 08 October 2014 
Gluten introduction in high risk children
 08 October 2014 
Vitamin D and HCC
 07 October 2014 
Infliximab in pediatric perianal Crohn's
 07 October 2014 
Omega-3 and NAFLD
 07 October 2014 
Endoscopic submucosal dissection in the colorectum 
 06 October 2014 
Clinical indications for computed tomographic colonography
 06 October 2014 
Certolizumab pegol in the treatment of Crohn's
 06 October 2014 
Costs of telaprevir therapy for Hep C
 03 October 2014 
Depression and liver transplantation
 03 October 2014 
Orange juice intake during bowel preparation
 03 October 2014 
HCV and diabetes
 02 October 2014 
Predictive model of Hep C disease progression
 02 October 2014 
IPAA with or without preoperative radiation
 02 October 2014 
Person-to-person transmission of norovirus
 01 October 2014 
Prevention of postop Crohn's
 01 October 2014 
Cecal intubation time during colonoscopy
 01 October 2014 
Anti-TNFa therapies during pregnancy in IBD
 30 September 2014 
Autoimmune hepatitis
 30 September 2014 
Medication use in patients with chronic Hep C
 30 September 2014 
Gastric cancer according to H pylori infection status
 29 September 2014 
Drug exposure and microscopic colitis
 29 September 2014 
Peptic ulcer bleeding after PPI treatment
 29 September 2014 
Intestinal tuberculosis vs Crohn's disease
 26 September 2014 
5-aminosalicylates for the treatment of Crohn's
 26 September 2014 
Response to infliximab in paediatric perianal Crohn's
 26 September 2014 
Ondansetron for IBS with diarrhea
 25 September 2014 
Medical treatment and surgery rates in IBD
 25 September 2014 
Liver transplants for liver cancer
 25 September 2014 
Colorectal neoplasia among family members of patients with colorectal cancer

Blackwell Publishing is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and and contributors
Privacy Statement
About Us